Xyon Health operates in the telehealth space with a focus on prescription-based care to target hair thinning and hair loss. Its services are structured around common haircare needs, including pattern hair loss, crown thinning, and weak hair strands.
Beyond haircare, the platform also provides access to virtual consultations and prescription offerings to tackle male sexual health concerns, including weak erections and erectile dysfunction.
This review will examine the platform’s structure, consultation flow, and the scope of its prescription and non-prescription offerings across hair and sexual health categories. It will also assess how clearly the platform explains its delivery technology, the accessibility of safety information, and ongoing user experience with the platform’s services.
About Xyon
Co-founded by Dr. Victor Hasson and Dr. Simon Pimstone, Xyon Health focuses on prescription-based hair regrowth support alongside male sexual care needs through its digital-first model.
The platform follows an online intake model where you answer questions about your concerns and medical history, after which a licensed provider may determine eligibility and create a personalized plan. Platform messaging also emphasizes that care is individualized, with eligibility dependent on clinical review rather than automatic approval.
Xyon’s haircare catalog includes prescription options such as Topical Finasteride, Topical Finasteride and Minoxidil, and Topical Dutasteride, offered in formats associated with the brand’s SiloxysSystem™ Gel. Added prescription offerings feature Topical Finasteride and Minoxidil Solution, Oral Finasteride, and Minoxidil Tablets. The non-prescription range features offerings like the Performance DHT-Blocking Shampoo, Performance DHT-Blocking Conditioner, and Defend Hair & Scalp Serum. As part of its male sexual care range, the platform may offer access to prescription offerings like Generic Viagra® (Sildenafil) and Generic Cialis® (Tadalafil).
Women’s haircare range features prescription offerings, including Topical Finasteride and Minoxidil, Topical Dutasteride, and Topical Finasteride and Minoxidil Solution, alongside oral options such as Spironolactone Tablets and Minoxidil Tablets.
As per its official website, SiloxysSystem™ is highlighted as a proprietary topical gel delivery format for haircare offerings. The brand states the gel forms a physical barrier (mesh-like layer) that helps hold the medication where it is applied and supports a controlled, time-release pattern. Such gradual release is described as using a concentration gradient concept to regulate how much medication enters the skin over time.
Xyon Offerings
Hair Care
The Hair Care range from Xyon is structured around prescription-based formulations supported by non-prescription scalp and hair maintenance products. Its services cover multiple haircare needs, including concerns such as hairline recession, crown thinning, diffuse thinning, and prevention.
As per its official site, the process begins with an online intake process where you submit health information and scalp or hair concerns through the platform. Licensed, board-certified physicians review the information and determine whether prescription formulas are appropriate based on medical criteria and regional licensing rules.
Within the prescription range, the platform may provide access to products like Topical Finasteride with SiloxysSystem™ Gel, Topical Finasteride and Minoxidil with SiloxysSystem™ Gel, Topical Dutasteride with SiloxysSystem™ Gel, a Topical Finasteride and Minoxidil Solution, and oral Finasteride and Minoxidil tablets. Non-prescription offerings feature options such as Performance DHT-Blocking Shampoo, Performance DHT-Blocking Conditioner, and Defend Hair & Scalp Serum. For women, the prescription offerings overlap in Topical Finasteride and Minoxidil Solution, Topical Dutasteride with SiloxysSystem™ Gel, alongside Minoxidil Tablets and Spironolactone Tablets.
Finasteride and dutasteride work by inhibiting the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT). DHT binds to androgen receptors in genetically sensitive hair follicles and gradually causes follicle miniaturization, leading to thinner, shorter hair shafts and eventual growth cessation. Finasteride selectively inhibits the type II form of this enzyme, while dutasteride inhibits both type I and type II, resulting in a greater reduction in scalp DHT levels.
Minoxidil works through a different mechanism by increasing potassium channel activity and local blood flow around hair follicles, which helps prolong the anagen (growth) phase of the hair cycle and increase follicle size. When used together, DHT suppression addresses the hormonal trigger of hair loss, while minoxidil supports follicle activity and hair shaft production, targeting separate but complementary biological pathways involved in androgenetic hair loss.
Sexual Health
As part of its Sexual Health range, the platform’s services are structured around prescription-based care for male sexual health needs, including concerns like erectile dysfunction and weak erections. Post-completion of an online intake process, licensed clinicians at the platform may approve prescriptions if appropriate for your reported needs and risk profile.
The range currently centers on two prescription medication options, namely Generic Viagra® (Sildenafil) and Generic Cialis® (Tadalafil). Both Sildenafil and Tadalafil work by inhibiting the phosphodiesterase type 5 (PDE5) enzyme in the smooth muscle of penile blood vessels, which slows the breakdown of cyclic guanosine monophosphate (cGMP). Higher cGMP levels might allow smooth muscle relaxation and increased blood flow into the corpus cavernosum during sexual stimulation for firmer erections.
Xyon Advantage
Licensed Clinician Led Framework
Xyon Health operates on a clinician-led care model that places licensed medical professionals at the center of care. The platform routes online consultations, medical intakes, and care decisions through board-certified physicians, not automated systems or non-clinical staff.
The brand openly positions its clinical leadership as guiding protocols and product development, tied to Dr. Victor Hasson, MD (inventor of SiloxysSystem™), Dr. Simon Pimstone, and Dr. Christina Han. Such an involvement signals that medical expertise shapes care decisions, not marketing priorities. Clinical oversight continues after care begins. Licensed providers monitor your response, adjust dosing, and address side effects as needed. Such a clinician-led framework builds credibility through regulated medical oversight. It clearly separates the platform from unregulated formulations and cosmetic-only products.
Xyon Limitation
Limited Established Brand Footprint
Xyon Health operates as a niche telehealth brand focused on prescription hair-loss care. It has a smaller market presence than legacy pharmaceutical companies or large consumer platforms with broad pharmacy and retail reach.
Products support medically guided hair-loss routines rather than everyday haircare. For example, the brand’s shampoo targets scalp hygiene and DHT management, not moisture, repair, or shine. The scalp serum centers on follicle support instead of styling or cosmetic benefits.
This care-first approach may limit mainstream awareness. While the strategy supports credibility in medical hair restoration, it keeps the platform’s footprint smaller than multi-category haircare companies that serve both clinical and cosmetic needs.
Pros
- Online intake, specialist review, and prescription management are built into the service, indicating a structured physician‑supervised flow.
- The platform offers compounded offerings to target diverse haircare needs, including hair fall, crowning, and thinning.
- Highlights the use of SiloxysSystem™ proprietary delivery technology aimed at improving efficacy and scalp retention of active ingredients.
Cons
- Absence of insurance coverage may lead to out-of-pocket medical costs.
- Some users on independent platforms noted delays in shipments and unresponsive support from the care team.
Xyon Alternatives
Rogaine
Rogaine and Xyon Health both focus on targeting hair loss concerns and present regrowth as a time-dependent process that requires consistency and long-term maintenance. However, the brands differ in their access model, product depth, and how clinical oversight is positioned.
The brand Rogaine functions as a topical hair regrowth brand centered on FDA-approved topical minoxidil, with a narrow, product-focused approach built around foam and topical formats for men and women. Xyon Health, meanwhile, operates as a doctor-founded telehealth platform offering prescription and non-prescription care across hair loss and men’s sexual health. The platform highlights consultation-based intake to generate a personalized plan and offers a broader product catalog that includes topical and oral prescription options.
The access experience is a major divide between the two models. Rogaine is positioned as an over-the-counter product brand where selection is mainly based on foam versus solution formats and gender segmentation, with Men’s Rogaine® Foam, Men’s Rogaine Solution, Women’s Rogaine Foam, and Women’s Rogaine Solution. The brand also offers one featured non-minoxidil formula called Men’s Thickening 2 in 1 Shampoo + Conditioner. Meanwhile, Xyon offers a prescription catalog across multiple actives and strengths. The platform offers access to offerings like Topical Finasteride with SiloxysSystem™ Gel, Topical Dutasteride with SiloxysSystem™ Gel, and Topical Finasteride and Minoxidil with SiloxysSystem™ Gel, alongside non-gel options such as Topical Finasteride and Minoxidil Solution. As part of its women’s haircare range, the platform offers products like Minoxidil Tablets, Topical Dutasteride, Spironolactone Tablets, and Topical Finasteride and Minoxidil. Beyond this, the platform also extends into the male sexual care space, with prescription-based offerings like Generic Cialis® (Tadalafil) and Generic Viagra® (Sildenafil).
Product and formulation identity are presented through different brand-owned technologies. Rogaine highlights Tricho Prime Technology, described as a system that begins working on contact and primes the scalp for hair regrowth. Minoxidil is described as penetrating the scalp to restore inactive follicles and increase protein production to lengthen the active growth phase. Xyon’s differentiation relies more heavily on delivery technology, centering its hair loss approach around SiloxysSystem™ Gel. It is described as a proprietary topical delivery system intended to keep medication localized to the scalp, control release over time, and reduce systemic exposure associated with side effects.
Keeps
When comparing Keeps and Xyon Health, both platforms operate within the telehealth haircare and sexual care space. However, they differ in origins, structural emphasis, range of offerings, level of clinical oversight provided, and service ecosystems. Founded in 2018 by Steve Gutentag and Demetri Karagas, Keeps is a U.S.-based telehealth platform and operates under the Thirty Madison healthcare ecosystem. The platform positions itself as an access-oriented service intended to lower barriers to established hair loss and sexual health medications through remote evaluation and subscription delivery. Meanwhile, Xyon Health presents itself as a doctor-founded telehealth platform, with Dr. Victor Hasson, MD, and Dr. Simon Pimstone, MD listed as co-founders.
Within the hair care space, Keeps offers prescription and non-prescription offerings to tackle concerns like crown thinning, receding hairline, weak hair strands, and thinning in men. Based on eligibility and clinical appropriateness, the prescription haircare range includes options such as Topical Finasteride and Minoxidil Gel, Finasteride Pills, Minoxidil+ Spray, and Ketoconazole Shampoo. The non-prescription range includes products like Minoxidil Foam, a Thickening range that features Shampoo, Conditioner, and Pomade, alongside Daily Hair Defense Supplement. Meanwhile, Xyon structures its hair care range across separate Men’s Hair and Women’s Hair verticals, clearly distinguishing prescription offerings from daily maintenance products. Some prescription-based options include the Topical Dutasteride with SiloxysSystem™ Gel, Topical Finasteride with SiloxysSystem™ Gel, Topical Finasteride and Minoxidil Solution, Topical Finasteride and Minoxidil with SiloxysSystem™ Gel, and Finasteride/Minoxidil tablets. Non-prescription range features products like Performance DHT-Blocking Shampoo/Conditioner and Defend Hair & Scalp Serum. Women’s haircare range mirrors this framework with offerings like Topical Finasteride and Minoxidil, Topical Dutasteride, Spironolactone Tablets, and Minoxidil Tablets.
Both platforms also extend into the sexual care space using similar medication classes, but with different framing. Keeps focuses on erectile dysfunction and premature ejaculation support through prescription offerings like Sildenafil Citrate and Tadalafil, along with non-prescription Climax Delay Spray, all accessed through the asynchronous intake and subscription model. Xyon Health also provides access to Generic Viagra® (Sildenafil) and Generic Cialis® (Tadalafil), but frames these options within as-needed or daily use structures that align with its broader emphasis on prescription continuity and clinician-directed pathways rather than simplified category expansion.
The consultation and care delivery model indicates similarity alongside minor nuances. Keeps relies exclusively on asynchronous telemedicine, where intake quizzes are reviewed by licensed providers who authorize prescriptions, manage refills, and communicate through an online dashboard. Meanwhile, Xyon Health provides fully remote digital consultations with board-certified dermatologists, personalized prescription offerings, discreet home delivery, and ongoing online support. However, the platform further lists trusted independent partners, such as hair transplant clinics and dermatologists across North America and Europe, who endorse Xyon products in their practices.
How Did We Evaluate?
Brand Credibility
In evaluating Xyon’s brand standing, we assessed the platform’s background, core positioning, and ratings across independent review forums. Xyon frames itself as a doctor-led telehealth platform built around the clinical credibility of its co-founders, Dr. Victor Hasson and Dr. Simon Pimstone. The topical lineup is highlighted as being structured around SiloxysSystem™ delivery gel technology to maximize absorption.
However, as of now, the platform maintains minimal to no presence across independent review forums like the Better Business Bureau, ThingTesting, and ConsumerAffairs. Such an absence of independent listings could make it difficult to assess practical reliability indicators such as customer service responsiveness, prescription onboarding clarity, refill and cancellation handling, and billing disputes.
Real User Feedback
To evaluate Xyon Health, we reviewed real user reviews shared across Reddit threads across 2025, focusing on how real users described outcomes, tolerability, satisfaction, and perceived value, especially around the platform’s topical finasteride and topical dutasteride offerings.
Across the Reddit discussions provided, the platform’s offerings are appreciated by users, especially those who prefer hair-loss stabilization and regrowth while reducing systemic exposure concerns. One long-term user described multi-year Topical Finasteride use followed by a multi-year switch to Xyon’s Topical Dutasteride, claiming sustained retention and near-complete crown recovery without side effects. It also reflects a more skeptical experience where the user chose a compounded topical dutasteride product, reporting early shedding, oily scalp, and later concluding that after extended use, there was no regrowth and that scalp greasiness and sebum issues were significant enough to stop product use.
Another user expressed that the platform’s topical Dutasteride use led to no improvement and perceived density loss, followed by a switch to oral dutasteride that triggered a heavy initial shed but was later associated with improved density.
Based on the available Reddit feedback, it appears that many users appreciated the platform’s oral finasteride/dutasteride offerings, highlighting decreased shedding, stabilization, and crown improvements over multi-month timelines. However, a few users describe a lack of regrowth even after extended periods, potential worsening density, dissatisfaction relative to oral dutasteride outcomes, and practical issues like oily hair/scalp and general hassle.
Frequently Asked Questions
Yes. The platform states that you can receive ongoing support from a board-certified dermatologist after the initial prescription and delivery. The brand describes follow-up care through the account portal, including the ability to request plan changes, renew prescriptions, and have plans reviewed when needed.
Yes. The platform’s haircare products, such as topical Finasteride and Minoxidil, may cause local scalp reactions. Reactions may include itching, irritation, dryness/flaking, and redness at the application site. The platform notes its SiloxysSystem™ gel is designed to improve tolerability, but it does not eliminate irritation risk, especially if you have a sensitive scalp.
Yes, it is possible. The platform notes that finasteride-containing products may be associated with male infertility or reduced semen quality in some cases. The brand also indicates that fertility effects are often reversible after discontinuation, and risk may be higher in cases of pre-existing fertility issues. It advises clinician consultation if planning to use such offerings when planning for conception.
Conclusion
Xyon Health positions itself as a telehealth platform focused on prescription hair-loss care and sexual care needs. The platform emphasizes a streamlined online intake model, use of proprietary ingredient delivery technology, and precision-compounded offerings produced through USP-compliant pharmacy partnerships.
However, the platform’s access model and clinical constraints create clear trade-offs. Coverage is fully cash-pay with subscription cycles, and there is no insurance coverage or reimbursement support, which can make long-term maintenance costly. Outcome variability and risk tolerance remain central considerations, as response to the brand’s offerings may depend on factors like genetics, hair-loss stage, adherence, and baseline follicle sensitivity to DHT.
Compounding also introduces added risk factors such as potency variability or contamination. Such factors make it important to weigh budget, risk comfort, and realistic maintenance expectations before relying on the platform’s services and offerings.
- About the Author
- Latest Posts
Alisha Matthew has been a practicing nutritionist since 2016. She holds a master’s degree in nutrition from the University of IOWA. She is a staunch believer in improving the human health index by educating people about nutrition and the importance of nutrition in leading a healthy and happy life. Her long-term goal is to keep educating people on general health and keep herself updated with the latest trends in the field of health.